187 related articles for article (PubMed ID: 21667821)
1. FOXC2 transcription factor: a novel regulator of lymphangiogenesis.
Wu X; Liu NF
Lymphology; 2011 Mar; 44(1):35-41. PubMed ID: 21667821
[TBL] [Abstract][Full Text] [Related]
2. Molecular lymphangiogenesis: new players.
Tammela T; Petrova TV; Alitalo K
Trends Cell Biol; 2005 Aug; 15(8):434-41. PubMed ID: 16005628
[TBL] [Abstract][Full Text] [Related]
3. Identification of targets of Prox1 during in vitro vascular differentiation from embryonic stem cells: functional roles of HoxD8 in lymphangiogenesis.
Harada K; Yamazaki T; Iwata C; Yoshimatsu Y; Sase H; Mishima K; Morishita Y; Hirashima M; Oike Y; Suda T; Miura N; Watabe T; Miyazono K
J Cell Sci; 2009 Nov; 122(Pt 21):3923-30. PubMed ID: 19825936
[TBL] [Abstract][Full Text] [Related]
4. The forkhead transcription factors, Foxc1 and Foxc2, are required for arterial specification and lymphatic sprouting during vascular development.
Seo S; Fujita H; Nakano A; Kang M; Duarte A; Kume T
Dev Biol; 2006 Jun; 294(2):458-70. PubMed ID: 16678147
[TBL] [Abstract][Full Text] [Related]
5. Mechanotransduction, PROX1, and FOXC2 cooperate to control connexin37 and calcineurin during lymphatic-valve formation.
Sabine A; Agalarov Y; Maby-El Hajjami H; Jaquet M; Hägerling R; Pollmann C; Bebber D; Pfenniger A; Miura N; Dormond O; Calmes JM; Adams RH; Mäkinen T; Kiefer F; Kwak BR; Petrova TV
Dev Cell; 2012 Feb; 22(2):430-45. PubMed ID: 22306086
[TBL] [Abstract][Full Text] [Related]
6. Regulation of pathological lymphangiogenesis requires factors distinct from those governing physiological lymphangiogenesis.
Hirakawa S
J Dermatol Sci; 2011 Feb; 61(2):85-93. PubMed ID: 21183319
[TBL] [Abstract][Full Text] [Related]
7. Regulation of lymphangiogenesis--from cell fate determination to vessel remodeling.
Karpanen T; Mäkinen T
Exp Cell Res; 2006 Mar; 312(5):575-83. PubMed ID: 16343484
[TBL] [Abstract][Full Text] [Related]
8. The role of Ang/Tie signaling in lymphangiogenesis.
Wu X; Liu N
Lymphology; 2010 Jun; 43(2):59-72. PubMed ID: 20848993
[TBL] [Abstract][Full Text] [Related]
9. VEGFs and receptors involved in angiogenesis versus lymphangiogenesis.
Lohela M; Bry M; Tammela T; Alitalo K
Curr Opin Cell Biol; 2009 Apr; 21(2):154-65. PubMed ID: 19230644
[TBL] [Abstract][Full Text] [Related]
10. Cdk5 and Foxc2--a new relationship in the lymphatic vasculature.
Liebl J
Oncotarget; 2015 Sep; 6(26):21799-801. PubMed ID: 26327394
[TBL] [Abstract][Full Text] [Related]
11. Polydom Is an Extracellular Matrix Protein Involved in Lymphatic Vessel Remodeling.
Morooka N; Futaki S; Sato-Nishiuchi R; Nishino M; Totani Y; Shimono C; Nakano I; Nakajima H; Mochizuki N; Sekiguchi K
Circ Res; 2017 Apr; 120(8):1276-1288. PubMed ID: 28179430
[TBL] [Abstract][Full Text] [Related]
12. Lymphangiogenesis by blind-ended vessel sprouting is concurrent with hemangiogenesis by vascular splitting.
Parsons-Wingerter P; McKay TL; Leontiev D; Vickerman MB; Condrich TK; Dicorleto PE
Anat Rec A Discov Mol Cell Evol Biol; 2006 Mar; 288(3):233-47. PubMed ID: 16489601
[TBL] [Abstract][Full Text] [Related]
13. Tumor-derived lymphangiogenic factors and lymphatic metastasis.
Cao Y; Zhong W
Biomed Pharmacother; 2007 Oct; 61(9):534-9. PubMed ID: 17904785
[TBL] [Abstract][Full Text] [Related]
14. Molecular control of lymphatic metastasis.
Achen MG; Stacker SA
Ann N Y Acad Sci; 2008; 1131():225-34. PubMed ID: 18519975
[TBL] [Abstract][Full Text] [Related]
15. Abnormal Shh and FOXC2 expression correlates with aberrant lymphatic development in human fetuses with increased nuchal translucency.
de Mooij YM; van den Akker NM; Bekker MN; Bartelings MM; Wisse LJ; van Vugt JM; Gittenberger-de Groot AC
Prenat Diagn; 2009 Sep; 29(9):840-6. PubMed ID: 19548265
[TBL] [Abstract][Full Text] [Related]
16. Mechanotransduction activates canonical Wnt/β-catenin signaling to promote lymphatic vascular patterning and the development of lymphatic and lymphovenous valves.
Cha B; Geng X; Mahamud MR; Fu J; Mukherjee A; Kim Y; Jho EH; Kim TH; Kahn ML; Xia L; Dixon JB; Chen H; Srinivasan RS
Genes Dev; 2016 Jun; 30(12):1454-69. PubMed ID: 27313318
[TBL] [Abstract][Full Text] [Related]
17. The role of novel prognostic markers PROX1 and FOXC2 in carcinogenesis of oral squamous cell carcinoma.
Agnihotri NS; Astekar M
J Exp Ther Oncol; 2018 May; 12(3):171-184. PubMed ID: 29790306
[TBL] [Abstract][Full Text] [Related]
18. Foxc2 transcription factor: a newly described regulator of angiogenesis.
Kume T
Trends Cardiovasc Med; 2008 Aug; 18(6):224-8. PubMed ID: 19185813
[TBL] [Abstract][Full Text] [Related]
19. Transcription factor FOXC2 demarcates the jugular lymphangiogenic region in avian embryos.
Rutscher K; Wilting J
Lymphology; 2008 Mar; 41(1):11-7. PubMed ID: 18581954
[TBL] [Abstract][Full Text] [Related]
20. Molecular mechanisms of lymphangiogenesis in development and cancer.
Albrecht I; Christofori G
Int J Dev Biol; 2011; 55(4-5):483-94. PubMed ID: 21858772
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
